Dr. Garo Armen is the Chairman and Chief Executive Officer of Agenus Inc., a biotechnology company he co-founded in 1994, focused on pioneering immunotherapies to fight cancer.

These therapies hold promise for treating both cancer and a range of immune disorders, providing a versatile approach to managing complex diseases.

Dr. Armen began his career at Brookhaven National Laboratory after earning his Ph.D. in Physical Chemistry from the City University of New York.

Through grassroots initiatives, COAF has implemented over $100 million worth of projects, dramatically improving education, healthcare, and social programs across more than 100 villages.

[4] Born in Istanbul, Turkey, in 1953, Dr. Armen moved to the United States in 1970, where his career has spanned scientific innovation, corporate leadership, and philanthropy.